REG - Surgical Innovations - Grant of Options <Origin Href="QuoteRef">SUNU.L</Origin>

Surgical InnovationsAnnouncement

31/10/2017 07:06

RNS Number : 0230V
Surgical Innovations Group PLC
31 October 2017
Surgical Innovations Group plc
(the "Company")
Grant of Options
The Company announces that on 31 October 2017 options to acquire 31,000,000 ordinary shares of 1p each ("Ordinary Shares") were granted to directors and employees (the "New Options").
The number of New Options granted to directors and PDMRs is as follows:
Director/PDMR
Role
No. of options held previously
New Options granted
Total no. of options held





Melanie Ross
COO/CFO
4,750,000
3,000,000
7,750,000
Adam Power
Group Development Director
1,000,000
6,000,000
7,000,000
David Marsh
Group Commercial Director
1,000,000
6,000,000
7,000,000
Michael McMahon
Non-Executive Director
4,750,000
1,750,000
6,500,000
Charmaine Day
Company Secretary
1,500,000
1,500,000
3,000,000
Nigel Rogers
Chairman
-
1,750,000
1,750,000
All of the New Options are subject to an exercise price of 3.25p per share.
In the case of non-directors, New Options become exercisable on the third anniversary of the date of grant, subject to the individual remaining in the Company's employment at that time, and remain exercisable until the tenth anniversary of the date of grant.
For directors, New Options will only vest subject to the closing price of the Ordinary Shares being at or above one of the following milestones over ten consecutive trading days during the relevant period:
By
Share price
(p)


31-Dec-20
5.40
31-Dec-21
5.81
31-Dec-22
6.24
31-Dec-23
6.71
31-Dec-24
7.21
31-Dec-25
7.75
31-Dec-26
8.33
31-Dec-27
8.96
Subject to the New Options granted to directors having vested, they are exercisable between the third and tenth anniversaries of the date of grant.
The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on shares acquired. 
For further information please visit www.sigroupplc.com or contact:
Enquiries:
For further information please contact:
Surgical Innovations Group Plc
www.sigroupplc.com
Nigel Rogers, Executive Chairman
Tel: 0113 230 7597
Melanie Ross, COO & CFO
WH Ireland Limited (NOMAD & Broker)
Tel: 0113 394 6600
Tim Feather
Alex Bond


Walbrook PR
Tel: 020 7933 8780
or si@walbrookpr.com
Paul McManus
Mob: 07980 541 893
Lianne Cawthorne
Mob: 07584 391 303
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Melanie Ross
2
Reason for the notification
a)
Position/status
Chief Operating Officer and Chief Financial Officer, Surgical Innovations Group plc
b)
Initial notification/ Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Surgical Innovations Group plc
b)
LEI
2138004GHGUH3HUZE156
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1p
GB0004016704
b)
Nature of the transactions
Grant of options
c)
Price(s) and volume(s)
Price(s)
Volume(s)
3.25p
3,000,000
d)
Aggregated information
- Aggregated volume
- Price
N/A
N/A
e)
Date of the transaction
31 October 2017
f)
Place of the transaction
Outside a trading venue
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Adam Power
2
Reason for the notification
a)
Position/status
Group Development Director, Surgical Innovations Group plc
b)
Initial notification/ Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Surgical Innovations Group plc
b)
LEI
2138004GHGUH3HUZE156
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1p
GB0004016704
b)
Nature of the transactions
Grant of options
c)
Price(s) and volume(s)
Price(s)
Volume(s)
3.25p
6,000,000
d)
Aggregated information
- Aggregated volume
- Price
N/A
N/A
e)
Date of the transaction
31 October 2017
f)
Place of the transaction
Outside a trading venue
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
David Marsh
2
Reason for the notification
a)
Position/status
Group Commercial Director, Surgical Innovations Group plc
b)
Initial notification/ Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Surgical Innovations Group plc
b)
LEI
2138004GHGUH3HUZE156
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1p
GB0004016704
b)
Nature of the transactions
Grant of options
c)
Price(s) and volume(s)
Price(s)
Volume(s)
3.25p
6,000,000
d)
Aggregated information
- Aggregated volume
- Price
N/A
N/A
e)
Date of the transaction
31 October 2017
f)
Place of the transaction
Outside a trading venue
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Michael McMahon
2
Reason for the notification
a)
Position/status
Non-Executive Director, Surgical Innovations Group plc
b)
Initial notification/ Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Surgical Innovations Group plc
b)
LEI
2138004GHGUH3HUZE156
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1p
GB0004016704
b)
Nature of the transactions
Grant of options
c)
Price(s) and volume(s)
Price(s)
Volume(s)
3.25p
1,750,000
d)
Aggregated information
- Aggregated volume
- Price
N/A
N/A
e)
Date of the transaction
31 October 2017
f)
Place of the transaction
Outside a trading venue
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Charmaine Day
2
Reason for the notification
a)
Position/status
Company Secretary, Surgical Innovations Group plc
b)
Initial notification/ Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Surgical Innovations Group plc
b)
LEI
2138004GHGUH3HUZE156
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1p
GB0004016704
b)
Nature of the transactions
Grant of options
c)
Price(s) and volume(s)
Price(s)
Volume(s)
3.25p
1,500,000
d)
Aggregated information
- Aggregated volume
- Price
N/A
N/A
e)
Date of the transaction
31 October 2017
f)
Place of the transaction
Outside a trading venue
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Nigel Rogers
2
Reason for the notification
a)
Position/status
Chairman, Surgical Innovations Group plc
b)
Initial notification/ Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Surgical Innovations Group plc
b)
LEI
2138004GHGUH3HUZE156
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1p
GB0004016704
b)
Nature of the transactions
Grant of options
c)
Price(s) and volume(s)
Price(s)
Volume(s)
3.25p
1,750,000
d)
Aggregated information
- Aggregated volume
- Price
N/A
N/A
e)
Date of the transaction
31 October 2017
f)
Place of the transaction
Outside a trading venue

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHBRBDGUUXBGRG